ELI LILLY AND COMPANY Taxes Payable, Current
ELI LILLY AND COMPANY (LLY) had Taxes Payable, Current of $9.44 billion as of 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2025-10-30
- 2025-09-30: Taxes Payable, Current $9.44B.
- 2025-06-30: Taxes Payable, Current $6.96B.
- 2025-03-31: Taxes Payable, Current $6.18B.
- 2024-12-31: Taxes Payable, Current $1.12B.
| Period end | Taxes Payable, Current | Taxes Payable, Current as first filed |
|---|---|---|
| 2025-09-30 | $9.44B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $6.96B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $6.18B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $1.12B 10-Q · filed 2025-10-30 | |
| 2023-09-30 | $1.98B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.23B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.53B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $475.10M 10-Q · filed 2023-11-02 | |
| 2022-09-30 | $685.60M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $126.60M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $598.30M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $126.90M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $203.50M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $529.90M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $791.60M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $495.10M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $1.17B 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $1.46B 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $667.40M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $160.60M 10-K · filed 2021-02-17 | |
| 2019-09-30 | $180.70M 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $222.90M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $491.40M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $393.40M 10-K · filed 2020-02-19 | $404.00M 10-K · filed 2019-02-19 |
| 2018-09-30 | $409.20M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $464.90M 10-Q · filed 2018-07-25 | |
| 2018-03-31 | $693.00M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $522.50M 8-K · filed 2019-10-24 | $532.90M 10-K · filed 2018-02-20 |
| 2017-09-30 | $414.40M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $236.00M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $122.00M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $119.10M 10-K · filed 2018-02-20 | |
| 2016-09-30 | $183.00M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $88.00M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $114.60M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $358.90M 10-K · filed 2017-02-21 | |
| 2015-09-30 | $700.00M 10-Q · filed 2015-10-30 | |
| 2014-12-31 | $93.50M 10-K · filed 2016-02-19 | |
| 2013-12-31 | $254.40M 10-K · filed 2015-02-19 | |
| 2012-12-31 | $143.50M 10-K · filed 2014-02-19 | |
| 2011-12-31 | $261.60M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $144.40M 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $183.10M 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $315.20M 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $457.50M 10-K · filed 2012-02-24 | |
| 2010-09-30 | $281.00M 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $435.30M 10-Q/A · filed 2010-08-02 | |
| 2010-03-31 | $192.10M 10-Q · filed 2010-07-30 | |
| 2009-12-31 | $346.70M 10-K · filed 2011-02-22 | |
| 2009-09-30 | $275.90M 10-Q · filed 2009-10-30 | |
| 2009-06-30 | $342.80M 10-Q · filed 2009-07-31 | |
| 2008-12-31 | $229.20M 10-Q · filed 2009-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |